Cibinqo is a medication used to treat moderate to severe atopic dermatitis, also known as eczema.
Understanding Cibinqo
Cibinqo is specifically designed for adults and adolescents, 12 years of age and older, who suffer from atopic dermatitis. The medication is prescribed when topical treatments applied directly to the skin are either insufficient or cannot be used.
Key Features of Cibinqo:
- Target Condition: Moderate to severe atopic dermatitis (eczema).
- Patient Population: Adults and adolescents (12 years and older).
- Usage: For patients where topical treatments are not enough or cannot be used.
- Mechanism: Cibinqo works to alleviate the symptoms of eczema, such as itchy, red, and dry skin.
Who Can Use Cibinqo?
Cibinqo is prescribed for patients with the following conditions:
- Individuals diagnosed with moderate to severe atopic dermatitis.
- Patients who have not achieved adequate relief from topical skin treatments.
- Adolescents aged 12 years and older, as well as adults.
Why is Cibinqo Prescribed?
Cibinqo provides an alternative treatment route for individuals who:
- Have skin conditions that do not improve with traditional topical applications.
- Cannot use topical treatments due to various reasons, such as skin sensitivity.
By offering a systemic approach, Cibinqo helps to manage the symptoms of atopic dermatitis effectively, leading to improved quality of life for those who suffer from eczema.
